Source: Virtual Congress 2021 – Therapy of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kouvela (Athens, Greece), D. Stefanou (Athens, Greece), L. Stournara (Athens, Greece), E. Ntalakou (Athens, Greece), F. Sarropoulou (Athens, Greece), N. Syrigos (Athens, Greece), I. Gkiozos (Athens, Greece). Thromboprophylaxis in lung cancer patients with intermediate tinzaparin dose: The iCaLT study. 2311

Member's Comments

No comment yet.

Related content which might interest you: Chemotherapy induced neutropenia in lung cancer patients: a single centre study Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Comparing different initial doses of afatinib used as first-line treatment for patients with stage IV lung adenocarcinoma Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Phase II open-label study to investigate efficacy and safety of PTK787/ZK 222584 (PTK/ZK) orally administered once daily at 1250 mg as second-line monotherapy in patients (pts) with stage IIIB/IV non-small-cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006 The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006 Short-time exercise-induced rehabilitation in non-small cell lung cancer patients during in-hospital chemotherapy treatment: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 Lung volume reduction surgery in patients with early-stage lung cancer: a single-center study Source: Eur Respir J 2007; 30: Suppl. 51, 433s Year: 2007 Mianserin therapy in advanced lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002 Determinants of physical activity in individuals with lung cancer who has received chemotherapy: pilot study Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Weekly administration of gemcitabine in outpatient clinic for the patients with recurrent non-small cell lung cancer after pulmonary resection Source: Eur Respir J 2006; 28: Suppl. 50, 781s Year: 2006 Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Pulmonary rehabilitation after radically treated lung cancer patients: a pilot study Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008 SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020 Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003 The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005 Second-line treatment patients at relapse of disseminated small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001 Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004 Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer Source: Eur Respir J 2006; 27: 1183-1189 Year: 2006 Anti-cancer therapy and monitoring plasma concentration of carboplatin in lung cancer patients receiving hemodialysis Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012